Document Detail


Intrahepatic cholesterol stones: a rationale for dissolution therapy.
MedLine Citation:
PMID:  1983825     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A case of primary cholesterol hepatolithiasis is reported. Stone composition was documented by infrared spectroscopy, and the presence of cholesterol saturated bile was demonstrated using standard biochemical techniques. The patient was treated with operative stone extraction, choledochoscopy, biliary enteric anastomosis, and oral dissolution therapy. The administration of oral dissolution agents has altered the composition of the patient's bile and may prevent further stone formation. We advocate the use of both stone and biliary biochemical analysis for patients with primary hepatolithiasis to facilitate optimal therapy.
Authors:
S D Strichartz; M Z Abedin; A F Ippoliti; M Derezin; J J Roslyn
Related Documents :
15501665 - Treatment of strong domestic sewage in a 96 m3 uasb reactor operated at ambient tempera...
18294035 - Ureteroscopic pneumatic lithotripsy: is the location of the stone important in decision...
10840415 - Caliceal diverticular calculi: is there a role for metabolic evaluation?
14744355 - Treatment of ureteral calculi with ballistic lithotripsy.
12810145 - Dropout from 12-step self-help groups: prevalence, predictors, and counteracting treatm...
24101955 - The comparison of feasibility and safety on fiberoptic guided intubation under consciou...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Gastroenterology     Volume:  100     ISSN:  0016-5085     ISO Abbreviation:  Gastroenterology     Publication Date:  1991 Jan 
Date Detail:
Created Date:  1991-01-10     Completed Date:  1991-01-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0374630     Medline TA:  Gastroenterology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  228-32     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, University of California School of Medicine, Los Angeles.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bile / chemistry
Bile Ducts, Intrahepatic*
Chenodeoxycholic Acid / therapeutic use
Cholelithiasis / chemistry*,  therapy*
Cholesterol / analysis*
Humans
Male
Middle Aged
Postoperative Period
Ursodeoxycholic Acid / therapeutic use
Chemical
Reg. No./Substance:
128-13-2/Ursodeoxycholic Acid; 474-25-9/Chenodeoxycholic Acid; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physicochemical determinants of in vitro shock-wave biliary lithotripsy.
Next Document:  Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.